APA   Click to copy
van Leth, F., Huisamen, C. B., Badaró, R., Vandercam, B., de Wet, J., Montaner, J., … Lange, J. (2005). Plasma HIV-1 RNA Decline Within the First Two Weeks of Treatment Is Comparable for Nevirapine, Efavirenz, or Both Drugs Combined and Is Not Predictive of Long-Term Virologic Efficacy: A 2NN Substudy. Journal of Acquired Immune Deficiency Syndromes.

Chicago/Turabian   Click to copy
Leth, F. van, Casper B Huisamen, R. Badaró, B. Vandercam, J. de Wet, J. Montaner, D. Hall, F. Wit, and J. Lange. “Plasma HIV-1 RNA Decline Within the First Two Weeks of Treatment Is Comparable for Nevirapine, Efavirenz, or Both Drugs Combined and Is Not Predictive of Long-Term Virologic Efficacy: A 2NN Substudy.” Journal of Acquired Immune Deficiency Syndromes (2005).

MLA   Click to copy
van Leth, F., et al. “Plasma HIV-1 RNA Decline Within the First Two Weeks of Treatment Is Comparable for Nevirapine, Efavirenz, or Both Drugs Combined and Is Not Predictive of Long-Term Virologic Efficacy: A 2NN Substudy.” Journal of Acquired Immune Deficiency Syndromes, 2005.

@article{f2005a,
  title = {Plasma HIV-1 RNA Decline Within the First Two Weeks of Treatment Is Comparable for Nevirapine, Efavirenz, or Both Drugs Combined and Is Not Predictive of Long-Term Virologic Efficacy: A 2NN Substudy},
  year = {2005},
  journal = {Journal of Acquired Immune Deficiency Syndromes},
  author = {van Leth, F. and Huisamen, Casper B and Badaró, R. and Vandercam, B. and de Wet, J. and Montaner, J. and Hall, D. and Wit, F. and Lange, J.}
}